MARKETING ANALYSIS OF THE RUSSIAN IMMUNOBIOLOGICAL MEDICINES MARKET WITHIN THE FRAMEWORK OF VACCINES

Abstract

The growth rates of immunobiological medicines sales volume, including vaccines, in the Russian pharmaceutical market from 2013 to 2018 is analyzed. The maximum growth rates of the studied indicators were noted in 2014 and 2015. The monotonous tendency of studied indicators increase in the subsequent period is noted. The share of sales volumes of vaccines in the general structure of immunobiological medicines consumption and dynamics of producers countries sales volumes of vaccines in Russia in real and cost index is studied. It is established that the share of consumption of vaccines of domestic production increased every year and today makes up 80%. Domestic leaders in sales volumes of vaccines in dynamics - NGO Microgen, Fort, LLC NPO Petrovax Pharm are revealed. Leaders in the volume of import of vaccines to Russia are Pfizer, Inc., the USA and Sanofi Pasteur, France. The leading positions in the ratings of indicators of export volume of pharmaceutical products from Russia are taken in recent years by J07 group of Vaccine.